Teenager who researched medical cannabis to study at Oxford
Ariana, from Barry in Wales, carried out research examining the extent THC, a component of cannabis, can 'negatively affect sleep architecture' as part of her studies.
The project highlighted the drug's promise, as well as gaps in existing research.
'There were only seven studies worth citing,' Ariana, a scholarship student at Cardiff Sixth Form College, said.
'I expected clearer answers, but what I found was a real need for more in-depth, unbiased research. This is something I want to keep exploring at university and beyond.'
Ariana's interest in medical cannabis is personal as well as academic.
Her mother lives with Crohn's disease, a chronic inflammatory bowel condition with no cure, and medical cannabis has played a crucial role in improving her quality of life.
Her parents run a medical cannabis clinic in Wales – Cannabis Clinic Cardiff – where the teenager has spent the last two years helping with admin and learning about the evolving science behind the plant-based treatment.
She said: 'Seeing my mum's condition and the way cannabis helped her and the patients who visit our clinic really opened my eyes to its medical potential.
'My dad is also a senior psychiatrist, so I've grown up in a household where science and care come together.'
Outside of school, Ariana earned gold in the Biology Olympiad, reached the semi-finals in the International Biology Bowl, and is also a competitive ice skater, having competed in the juvenile British championships in 2020 for synchronised ice skating.
Now preparing for Oxford, Ariana plans to channel her energy into drug development and mental health research – with a special interest in how medical cannabis could one day transform care.
'There's still stigma and strong media opinions,' she said.
'But science is about asking difficult questions and being open to where the evidence leads.'
Welsh Education Secretary Lynne Neagle extended her congratulations to students picking up their results on Thursday.
She said: 'Every learner opening their results today has earned the right to feel immense pride in what they've accomplished, and these achievements demonstrate remarkable determination.
'As you look towards your future, whether that involves starting an apprenticeship, entering employment, or beginning studies at university, I wish you 'pob lwc'.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wales Online
2 hours ago
- Wales Online
Much-needed Welsh hospital might never be built, health bosses admit
Much-needed Welsh hospital might never be built, health bosses admit Plans for a new hospital in Carmarthenshire have been on the table for years but no land has been purchased and no funding secured. So what is happening with healthcare in west Wales? Glangwili Hospital in Carmarthen, which opened in the 1940s. Ambitious plans to downgrade it and build a new hospital in Carmarthenshire have seemingly been put on ice (Image: Western Mail) Health bosses have admitted they may never be able to afford a new hospital in west Wales almost 20 years after the ambitious plans were first proposed. The idea of constructing a new 'super-hospital' in the region was first discussed back in 2006 and in 2018 Hywel Dda University Health Board, which is responsible for healthcare provision across Carmarthenshire, Pembrokeshire, and Ceredigion, officially unveiled its proposals to build the new urgent and planned care hospital to the west of Carmarthen in an area near St Clears or Whitland. The project was estimated to cost more than £1bn in total and would result in the downgrading of Glangwili Hospital in Carmarthen and Withybush Hospital in Haverfordwest. Stay informed on Carms news by signing up to our newsletter here . The A&E departments at both of those existing hospitals would be shut down with a new A&E department being housed at the new site – around nine miles from Carmarthen and around 25 miles from Llanelli. We are now seven years on from the launch of the official plans and yet the beginning of construction has never seemed further away. A long list of potential sites for the new hospital was whittled down to three and then two – agricultural land forming part of Ty Newydd Farm on the outskirts of Whitland and a site located less than a mile to the west of St Clears. But two years on from that decision no land has been purchased. Furthermore no funding has been secured to purchase any land. Article continues below There is scepticism among some members of staff at Glangwili Hospital – a sense that plans for a new hospital have been shelved entirely due to a lack of funds, rendering something once seen as ambitious now impossible. These concerns are amplified by continuing issues at existing Hywel Dda hospitals. At Glangwili parking continues to prove challenging for staff and visitors alike while multiple-hour waits at A&E have become common. Outside emergency ambulances have lined up with patients onboard, creating a backlog of sick people in need of a hospital bed and a shortage of available vehicles able to attend emergencies just a few miles away. Last year a rugby player was forced to lay injured on a cold and wet pitch because it took six hours for an ambulance to arrive in the village of Nantgaredig – five miles from the hospital. Glangwili Hospital in Carmarthen, which has been in operation for more than 75 years (Image: Mike Walters) Further east at Llanelli's Prince Philip Hospital things have looked similarly bleak. Locals have protested at the health board's controversial decision to close down a 24-hour minor injuries unit – a service it was promised would be maintained when the A&E department bit the dust around a decade ago. The closing down of the 24-hour minor injuries unit – which was reduced to 12 hours between 8am and 8pm – was only meant to be a six-month temporary measure. However the service will not return to what it once was, it has been confirmed. Instead four options for the unit's future have been put forward with a decision expected next month. Meanwhile a ward at the Llanelli hospital was told at the end of last year it needed to make several improvements following a surprise inspection. In a report Healthcare Inspectorate Wales highlighted fire doors being wedged open, cluttered areas near fire exits, and broken handrails at Bryngolau Ward. The report also recommended a full review of the audit and risk management procedures. In Pembrokeshire local MS Paul Davies said earlier this summer "enough is enough" regarding uncertainty over Haverfordwest's Withybush Hospital. This was following the initiation of a public consultation – which runs until the end of August – looking at possible changes to care provision including the transfer of patients requiring specialist critical care to Glangwili, which is more than 30 miles away. Protesters outside Prince Philip Hospital in Llanelli last year (Image: John Myers) It all paints an uncertain picture for the future of healthcare provision in west Wales and with no new hospital in sight – despite one initially being slated for a 2029 opening – that picture is unlikely to become any clearer in the coming years. The health board keeps using the word 'if' with regards to the new build. Last year the board's chief executive, Phil Kloer, said: 'A new hospital is going to be at least 10 years and maybe longer in arriving'. Nine months later nothing has happened. 'In February 2022 we submitted a Programme Business Case to the Welsh Government, which estimated costs for a new urgent and planned care hospital and other essential building work in excess of £1bn,' said the health board's medical director Mark Henwood. 'This represents a significant affordability challenge for the Welsh Government and we are still working through how we might achieve this and in what timeframe. 'In November 2024 the board discussed how we estimated that delivery of a new hospital, if achieved, is likely to be at least 10 years. Major projects such as this take many years to develop and we continue to work with the Welsh Government on the way forward.' The health board has now said it needs to figure out ways to 'support fragile services' in existing hospitals and is asking members of the public to contribute to a review of its A Healthier Mid and West Wales strategy, first published in 2018. Mr Henwood added: 'In accepting that a new hospital will not be operational in the near future we need to consider how we support fragile services ahead of a new facility and within existing hospital buildings. The Clinical Services Plan consultation considers nine healthcare services that are at risk of being able to continue to offer safe, quality services or timely care in the coming years. 'Additionally we are reviewing our 2018 strategy, also discussed as part of our board meetings in public, and we are asking our population to let us know what they think is important to them to lead a healthy life.' Article continues below A spokesman for the Welsh Government said: "Large infrastructure projects take time to develop and in the meantime we continue to work with Hywel Dda on service options and ongoing investment requirements across their estate. Future investments will be informed by the work on a clinical services plan that will build on the strengths of each site within Hywel Dda's clinical estate.'
Wales Online
6 hours ago
- Wales Online
Parents warned about foods that could cause ADHD in children
Parents warned about foods that could cause ADHD in children Foods in children's diets, other than additives, may be triggering hyperactivity, says Swansea University scientist For years there has been concern that food additives and E numbers can cause ADHD in children, but now a leading Welsh scientist says other foods may be a factor and that additives are "unlikely to be the sole cause". Since 2010 any food or drink in both the UK and EU containing any of the food colour additives has had to carry a warning. But David Benton Professor Emeritus (Human & Health Sciences), Medicine Health and Life Science, Swansea University, says other foods could be to blame for Attention Deficit Hyperactivity Disorder (ADHD). His comments come as a new study also shows that ADHD drug treatment can reduce patients' suicidal behaviour. "Eating ultra-processed food – and therefore additives – is more common among low-income families, who are also at greater risk of ADHD," wrote Professor Benton. "To some extent ADHD may be an indication of poverty, and a generally poor diet, reflecting the financial need to eat cheaper ultra-processed foods." Writing in The Conversation, Professor Benton added: "Having a high intake of additives correlates with a high intake of ultra-processed food – usually a diet high in sugar and fat, while low in fibre, protein, vitamins and minerals. So, why assume that additives are the problem, and not the rest of the diet?" Article continues below Read the biggest stories in Wales first by signing up to our daily newsletter here Profesor Benton believes "there was no scientific justification" for it, but out of precaution, since 2010 ,any food or drink in both the UK and EU containing any of the colour additives has had to carry a warning. The Swansea University expert said non- processed foods could also cause different responses in individuals. He quoted another study on the Isle of Wight in 2007 which tried elimintating a variety of foods from children's diets to see what may cause hyperactivity. "Food additives are unlikely to be the sole cause of ADHD in children . If a child's behaviour seems linked to diet, keeping a food diary can help identify patterns. "But any elimination diet should be approached with care and expert advice, to avoid doing more harm than good. Ultimately, every child is different, and what works for one may not work for another." "There's a common assumption that natural chemicals are good, while synthetic ones are bad. But what matters isn't how a chemical is made but how the body responds." Hyperactivity can be a response to anxiety, excitement, sleep problems or sensory overload and is not exclusive to ADHD . ADHD is a condition with symptoms such as lack of concentration,, hyperactivity and impulsivity. While there is no one cause alone Risk factors are believed to include genetics, prenatal substance exposure, toxins like lead, low birth weight and early neglect. Read more: 13 signs of ADHD in adults that often go unnoticed Professor Benton said that to better understand the link between diet and hyperactivity, researchers looked at what's known as the "few foods" diet. In this children are given a very limited menu, then foods are gradually reintroduced to see what triggers a reaction. The first study using this method was carried out in London in 1985. It found that at least one of the children reacted adversely to 48 of the foods in their diet with signs of hyperactivity. "With cows' milk this was true for 64% of children in the study. For grapes it was 49%, hens' eggs 29%, fish 23%, apples 13% and tea 10%. These are not ultra-processed foods, but we need to explore whether they contain chemicals that influence the biology of some individuals. "As many as 79% of children reacted to a preservative and a colouring, although the doses used were greater than would be normally consumed. "And as no child reacted only to these additives, and different children reacted to different foods, only removing additives wouldn't eliminate symptoms." All the children in the study also had a history of allergic reactions, so their responses to food may have reflected a biological predisposition, the professor cautioned,# Professor Benton said a 2017 review concluded 'there is convincing evidence for the beneficial effect of a few-foods diet on ADHD'. It suggested the few foods diet offered a 'treatment for those with ADHD not responding to, or too young for, medication'. Article continues below
Spectator
7 hours ago
- Spectator
Mounjaro won't be the last drug company to bow to Trump
If you need to lose a few pounds after enjoying the French or Italian food a little too much on your summer holiday, there might soon be a problem. The cost of one of the new weight loss drugs that has become so popular in recent months is about to get a lot more expensive. The American drugs giant Eli Lilly doubling the price of Mounjaro in the UK. The price of one diet pill does not make a great deal of difference. The trouble is, the decision was prompted by President Trump's determination to make the cost of medicines a lot fairer between the United States and the rest of the world. This is going to end up costing Britain, along with many other countries, a lot of money. Eli Lilly will be increasing the British price of Mounjaro, the most popular and effective weight loss injection, from £92 for a medium-sized dose to £180, and from £122 to £330 for a stronger version. The reason is simple. President Trump, with his typically blunt language, complained about how a friend of his brought 'the fat drug' in London at a far lower price than in the US despite being 'the same box made in the same plant by the same company'. More broadly, President Trump has made a big issue of the huge differences in drug prices between the US and other countries. He has imposed tariffs that could go as high as 250 per cent to force the major pharmaceutical companies to bring their manufacturing onshore and lower prices for American patients. Eli Lilly's response, quite rationally, has been to increase the price in the UK to start to close the gap and keep the President happy. Eli Lilly won't be the last pharmaceutical company to do this. Truth be told, President Trump has a point about the unfairness of drug prices in his country. On average, medicines cost 2.7 times more in the US than they do in the rest of the world. That might make sense for poor countries, but it is hard to see why developed economies in Europe, the Gulf or Asia should pay so much less for medicines than America does. In effect, the US subsidises the rest of the world, paying for the huge cost of research while the rest of the world gets drugs at far less than they would otherwise cost. But if that is rebalanced, medicines will inevitably get a lot more expensive, both for private patients and in time for the NHS as well. Given that the UK spends £34 billion a year on pharmaceuticals and that £19 billion of that comes from the NHS, that is going to be a very big bill – and one that we can barely afford.
